Washington D.c. Veterans Affairs Medical Center

This study aims to understand how two kidney-protective medications, finerenone and empagliflozin, work in African American veterans with diabetes-related kidney disease. Researchers will measure specific markers of kidney injury in urine and blood to see how these drugs affect k…